炎症
生物
细胞生物学
成纤维细胞
医学
免疫组织化学
细胞外基质
病理
纤维化
癌症研究
分子生物学
化学
基因表达
转录组
作者
Nobuhiro Naito,Hiroaki Kasashima,Tatsunari Fukuoka,Yuki Nakanishi,Naoko Ohtani,Kiyoshi Maeda
出处
期刊:Neoplasia
[Elsevier BV]
日期:2026-04-21
卷期号:77: 101310-101310
被引量:2
标识
DOI:10.1016/j.neo.2026.101310
摘要
Inflammatory bowel disease-associated colorectal cancer (IBD-CRC) represents a distinct clinical and molecular entity characterized by long-standing inflammation and a unique "dysplasia-carcinoma" sequence. While epithelial genetic alterations are well-documented, the role of the mesenchymal stroma as a dynamic driver of malignant transformation remains underappreciated. In this review, we propose a conceptual framework where intestinal fibroblasts contribute significantly to niche construction as key components of the Tumor Microenvironment (TME) architecture. These cells are not merely passive scaffolds but dynamically co-evolve with the epithelium and immune compartment, transitioning into active orchestrators of the pre-malignant niche. We highlight the emerging concept of "stromal inflammatory memory," which is hypothesized to be encoded through stable epigenetic imprinting and persistent metabolic reprogramming, characterized by a PFKFB3-mediated glycolytic shift. This metabolic priming sustains a pro-tumorigenic environment even during clinical remission. We further delineate how the loss of apical polarity regulators, such as aPKC, triggers a cascade of epithelial-stromal crosstalk involving chronic microbial sensing and hyaluronan-driven signaling. This co-evolution leads to the diversification of cancer-associated fibroblast (CAF) subsets, including inflammatory (iCAF), myofibroblastic (myCAF), and antigen-presenting (apCAF) populations. These subsets collectively orchestrate immune evasion via T-cell exhaustion and physical immune exclusion. Finally, we discuss the clinical implications of the "Reverse Warburg Effect" and exosome-mediated chemoresistance. We emphasize that effective therapeutic strategies must transcend epithelial-centric models to target the stromal axis. By integrating recent advances in single-cell and spatial transcriptomics, we identify novel opportunities for "stromal reprogramming" through metabolic, epigenetic, and senomorphic interventions to prevent and treat IBD-CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI